LONDON (Thomson Financial) - Taihua Plc said it has resumed production of
Chinese traditional medicines after receiving approval from China's State Food
and Drug Administration.
Taihua said on July 30 production had been suspended after a review of its
licences.
tf.TFN-Europe_newsdesk@thomson.com
ra
COPYRIGHT
Copyright Thomson Financial News Limited 2008. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.
|